End-of-day quote
Other stock markets
|
||
- USD | - |
Apr. 25 | Sector Update: Health Care Stocks Decline Late Afternoon | MT |
Apr. 25 | Perrigo Receives Binding Offer to Sell HRA Pharma Rare Diseases Business for Up to $295 Million | MT |
Financials (USD)
Sales 2024 * | 4.66B | Sales 2025 * | 4.86B | Capitalization | 4.24B |
---|---|---|---|---|---|
Net income 2024 * | -51M | Net income 2025 * | 101M | EV / Sales 2024 * | 1.59 x |
Net Debt 2024 * | 3.18B | Net Debt 2025 * | 3.01B | EV / Sales 2025 * | 1.49 x |
P/E ratio 2024 * |
-83.8
x | P/E ratio 2025 * |
55.8
x | Employees | - |
Yield 2024 * |
3.52% | Yield 2025 * |
3.75% | Free-Float | 99.69% |
Latest transcript on Perrigo Company
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 55 | 23-06-29 | |
Eduardo Bezerra
DFI | Director of Finance/CFO | 49 | 22-05-15 |
Alison Ives
CTO | Chief Tech/Sci/R&D Officer | - | 14-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Orlando Ashford
CHM | Chairman | 55 | 20-12-14 |
Jeffrey Kindler
BRD | Director/Board Member | 68 | 17-02-05 |
Bradley Alford
BRD | Director/Board Member | 67 | 17-02-05 |
1st Jan change | Capi. | |
---|---|---|
+24.91% | 556B | |
-6.33% | 354B | |
+19.90% | 331B | |
+7.95% | 296B | |
+13.80% | 233B | |
+5.75% | 201B | |
-10.22% | 193B | |
-12.26% | 143B | |
-6.47% | 144B |